Virtus ETF Advisers LLC Arcellx, Inc. Transaction History
Virtus ETF Advisers LLC
- $206 Million
- Q3 2024
A detailed history of Virtus ETF Advisers LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,651 shares of ACLX stock, worth $145,007. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,651
Previous 1,623
1.73%
Holding current value
$145,007
Previous $89,000
53.93%
% of portfolio
0.07%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding ACLX
# of Institutions
205Shares Held
44.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$351 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$342 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$329 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$309 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$216 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.85B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...